This document provides guidance on the pharmaceutical data applicable to product information for human vaccines. It covers information to be provided for the summary of product characteristics, labeling and package leaflet.
Keywords: Vaccine, label, summary of product characteristics, patient leaflet, braille
Current effective version
Guideline on quality aspects included in the product information for vaccines for human use - Revision 1
Document history
Guideline on quality aspects included in the product information for vaccines for human use - Revision 1
Overview of comments received on 'Guideline on quality aspects included in the product information for vaccines for human use' (EMA/CHMP/BWP/133540/2017) - Revision 1
Draft guideline on quality aspects included in the product information for vaccines for human use - Revision 1
Concept paper on a revision of the guideline on pharmaceutical aspects of the product information for human vaccines (EMEA/CPMP/BWP/2758/02) - Revision 1
Guideline on pharmaceutical aspects of the product information for human vaccines - First version